Daily as of 2 Nov 16:00 ET
- Price
- below both $9.70 vs 50 $11.85 / 200 $14.46
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 21 Sep 2026 · projected 19 bars out
CRVS | Corvus PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$9.70
-$0.33 (-3.29%)
Corvus Pharmaceuticals (CRVS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $10.03 vs 50 $13.25 / 200 $5.87
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 9 Sep 2024 · projected 15 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- below both $9.83 vs 50 $10.25 / 200 $12.90
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 24 Sep 2026 · projected 28 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 24 Sep 2026 | 💀Death | 4-hour | 28 bars out | Not tested |
| 21 Sep 2026 | 💀Death moderate | daily | 19 bars out | Not tested |
| 27 Aug 2026 | 🟨Golden | 4-hour | 5 bars out | 5 bar cross test |
| 17 Aug 2026 | 💀Death | 4-hour | 22 bars out | 2 bar cross test |
| 24 Jul 2026 | 🟨Golden | 4-hour | 25 bars out | Not tested |
About CRVS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$11.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall